Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Panacea Life Sciences Holdings, Inc. (EXDI) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Panacea Life Sciences Holdings, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1552189.
Total stock buying since 2019: $64,796.
Total stock sales since 2019: $0.
Total stock option exercises since 2019: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 62,500 | $22,028 | 0 | $0 | 0 | $0 |
| 2022 | 74,550 | $17,768 | 0 | $0 | 0 | $0 |
| 2019 | 62,500 | $25,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-09 | 20,000 | $4,740 | 0 | $0 | 0 | $0 |
| 2023-05 | 21,800 | $10,486 | 0 | $0 | 0 | $0 |
| 2023-04 | 16,700 | $6,069 | 0 | $0 | 0 | $0 |
| 2023-02 | 4,000 | $733 | 0 | $0 | 0 | $0 |
| 2022-08 | 48,800 | $5,893 | 0 | $0 | 0 | $0 |
| 2022-07 | 7,700 | $2,273 | 0 | $0 | 0 | $0 |
| 2022-04 | 18,050 | $9,602 | 0 | $0 | 0 | $0 |
| 2019-12 | 62,500 | $25,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-18 | Buttorff Leslie (CEO) | Buy | 20,000 | .24 | 4,740 |
| 2023-05-23 | Buttorff Leslie (CEO) | Buy | 500 | .50 | 249 |
| 2023-05-19 | Buttorff Leslie (CEO) | Buy | 6,000 | .52 | 3,090 |
| 2023-05-09 | Buttorff Leslie (CEO) | Buy | 2,300 | .38 | 867 |
| 2023-05-08 | Buttorff Leslie (CEO) | Buy | 1,500 | .43 | 645 |
| 2023-05-05 | Buttorff Leslie (CEO) | Buy | 11,500 | .49 | 5,635 |
| 2023-04-26 | Buttorff Leslie (CEO) | Buy | 5,500 | .40 | 2,189 |
| 2023-04-25 | Buttorff Leslie (CEO) | Buy | 4,500 | .35 | 1,575 |
| 2023-04-05 | Buttorff Leslie (CEO) | Buy | 2,500 | .33 | 825 |
| 2023-04-04 | Buttorff Leslie (CEO) | Buy | 3,200 | .35 | 1,120 |
| 2023-04-03 | Buttorff Leslie (CEO) | Buy | 1,000 | .36 | 360 |
| 2023-02-27 | Buttorff Leslie (CEO) | Buy | 3,000 | .18 | 543 |
| 2023-02-26 | Buttorff Leslie (CEO) | Buy | 1,000 | .19 | 190 |
| 2022-08-26 | Buttorff Leslie (CEO) | Buy | 15,000 | .14 | 2,070 |
| 2022-08-11 | Wert Lawrence | Buy | 15,000 | .13 | 1,965 |
| 2022-08-04 | Buttorff Leslie (CEO) | Buy | 17,800 | .10 | 1,762 |
| 2022-08-03 | Buttorff Leslie (CEO) | Buy | 1,000 | .10 | 96 |
| 2022-07-11 | Buttorff Leslie (CEO) | Buy | 3,600 | .43 | 1,544 |
| 2022-07-08 | Buttorff Leslie (CEO) | Buy | 4,100 | .18 | 729 |
| 2022-04-05 | Buttorff Leslie (CEO) | Buy | 1,050 | .48 | 507 |
| 2022-04-04 | Buttorff Leslie (CEO) | Buy | 17,000 | .54 | 9,095 |
| 2019-12-18 | Johnson Andrew L. (CHIEF STRATEGY OFFICER) | Buy | 62,500 | .40 | 25,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of EXDI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Panacea Life Sciences Holdings, Inc. (symbol EXDI, CIK number 1552189) see the Securities and Exchange Commission (SEC) website.